The bacteria Mycoplasma pneumoniae can trigger Guillain-Barre syndrome in which the body’s immune attacks the nerves and incites paralysis, according to a recent study published in the journal ...

The peptides that make up the immunoreactive epitopes of SARS-CoV-2 were shown to share the same sequences as heat shock proteins 90 and 60 – both associated with Guillain-Barre syndrome – but ...

Johnson & Johnson’s beleaguered Covid-19 vaccine may be associated with a small increased risk of Guillain-Barré syndrome, a rare but potentially serious neurological condition, federal ...

Annexon announces positive topline results from pivotal phase 3 trial for first-in-class C1q blocking antibody ANX005 in Guillain-Barré syndrome. News release. Annexon, Inc. June 4, 2024.

A large swine flu vaccination campaign in 1976 led to a small uptick in the incidence of syndrome; the vaccine caused roughly one extra case of Guillain-Barré for every 100,000 people vaccinated.

Guillain-Barre syndrome (GBS) is a rare but serious autoimmune disorder in which the body's immune system mistakenly attacks the peripheral nerves, leading to muscle weakness, numbness, and, in ...

Having a COVID-19 infection is associated with an increased risk of developing the rare disorder called Guillain-Barré syndrome within the next six weeks, according to a study published in the ...

NEW YORK (AP) — Reports of a rare nervous system disorder were “more common than expected” in older U.S. adults who got the new RSV vaccines, according to a Centers for Disease Control and ...

An estimated 3,000 to 6,000 people develop Guillain-Barre syndrome in the U.S. each year — either after being infected by a virus or linked to a vaccination — and it’s more common in older ...

An estimated 3,000 to 6,000 people develop Guillain-Barre syndrome in the U.S. each year — either after being infected by a virus or linked to a vaccination — and it’s more common in older ...